New treatment announced for idiopathic pulmonary fibrosis
Boehringer Ingelheim is developing a new therapy for idiopathic pulmonary fibrosis, described as the first such treatment in more than a decade.
By DoomRadar · Published on DoomRadar .
Why it matters
The treatment could affect care options for patients with a serious lung disease.
Related source links
These links were collected with this event. Recorded source dates may reflect when a link was found. Article publication dates are shown only when available from the source. Open the originals for their full context.
No matching source link is available in the saved records for this brief.
AI-assisted, source-based analysis. Methodology · Report a correction